22nd North American ISSX Meeting – Montréal, Canada (15th-19th July)

Dr Colin Brown will be attending the 22nd North American Meeting of the International Society for the Study of Xenobiotics between 15 – 19 July 2018 in Montréal, Québec, Canada.

The meeting brings together individuals who are working on drug/xenobiotic research across a diverse range of fields such as clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal chemistry, molecular and structural biology and genetics.

Two posters will be available for viewing between 16th-18th July in the Exhibition Hall. This will form part of the 2nd poster session on Tuesday 17th July from 12-2pm:  

Characterization of Cisplatin Toxicity in aProximateTM Human Proximal Tubule Cell Monolayers

Development of a Novel Predictive In Vitro Non-Human Primate Proximal Tubule Model for Drug Transporter and Nephrotoxicity Studies

Information of the aProximateTM assay will also be available throughout the meeting on the Solvo Biotechnology stand (Booth 210)

If you are attending the 22nd North American ISSX Meeting and would like to arrange a meeting with Dr Brown, to learn more about our product and services, then please let us know – https://newcellsbiotech.co.uk/collaborate

You might also be interested in…
retinal pigmented epithelium (RPE)
Blog

Newcells Biotech Ltd. RPE Model to Improve Drug Retinal Toxicity Assessment

Retinal toxicity is an adverse side effect that can cause (usually irreversible) deterioration of a person’s vision, when taking certain medication. This has been seen for example in people taking Hydroxychloroquine for Malaria due to toxicity to the retinal cells.  The retinal pigmented epithelium (RPE) is